Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine
Abstract
In Guinea-Bissau, children were randomised at 6 months of age to receive either two doses of standard-titre measles vaccine at 6 and 9 months of age or an inactivated polio vaccine at 6 months and standard-titre measles vaccine at 9 months of age. During the first 5 months, children received Edmonst …
Keywords
immunization
immunity
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
age factors
Infant
Clinical Trial
Randomized Controlled Trial
Antibodies
Measles / prevention & control
Measles Vaccine / administration & dosage*
viral / blood
dose-response relationship
immunization schedule
h c whittle
measles virus / immunology
viral / biosynthesis*
measles vaccine / immunology*
guinea-bissau
immunologic
maternally-acquired
secondary
pmid:11228365
doi:10.1016/s0264-410x(00)00431-x
m l garly
c balé
Citation
ID:
119618
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
119618
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet